FI66007C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporinderivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporinderivat Download PDF

Info

Publication number
FI66007C
FI66007C FI783960A FI783960A FI66007C FI 66007 C FI66007 C FI 66007C FI 783960 A FI783960 A FI 783960A FI 783960 A FI783960 A FI 783960A FI 66007 C FI66007 C FI 66007C
Authority
FI
Finland
Prior art keywords
formula
ppm
amino
syn
acid
Prior art date
Application number
FI783960A
Other languages
English (en)
Finnish (fi)
Other versions
FI66007B (fi
FI783960A (fi
Inventor
Juergen Blumbach
Walter Duerckheimer
Elmar Schrinner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI783960A publication Critical patent/FI783960A/fi
Application granted granted Critical
Publication of FI66007B publication Critical patent/FI66007B/fi
Publication of FI66007C publication Critical patent/FI66007C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI783960A 1977-12-24 1978-12-21 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporinderivat FI66007C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2758001 1977-12-24
DE19772758001 DE2758001A1 (de) 1977-12-24 1977-12-24 Cephalosporinderivate und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
FI783960A FI783960A (fi) 1979-06-25
FI66007B FI66007B (fi) 1984-04-30
FI66007C true FI66007C (fi) 1984-08-10

Family

ID=6027279

Family Applications (1)

Application Number Title Priority Date Filing Date
FI783960A FI66007C (fi) 1977-12-24 1978-12-21 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporinderivat

Country Status (20)

Country Link
US (1) US4293550A (xx)
EP (1) EP0002765B1 (xx)
JP (1) JPS5495592A (xx)
AT (1) AT365599B (xx)
AU (1) AU534258B2 (xx)
CA (1) CA1109461A (xx)
DE (2) DE2758001A1 (xx)
DK (1) DK578978A (xx)
EG (1) EG13762A (xx)
ES (1) ES476109A1 (xx)
FI (1) FI66007C (xx)
GR (1) GR65234B (xx)
HU (1) HU184140B (xx)
IE (1) IE48147B1 (xx)
IL (1) IL56284A (xx)
NO (1) NO784366L (xx)
NZ (1) NZ189266A (xx)
PH (1) PH15925A (xx)
PT (1) PT68964A (xx)
ZA (1) ZA787209B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703046A (en) * 1978-09-08 1987-10-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
NL8005440A (nl) * 1979-10-02 1981-04-06 Glaxo Group Ltd Cefalosporinen met antibiotische werking.
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
EP0055465B1 (en) 1980-12-31 1989-08-23 Fujisawa Pharmaceutical Co., Ltd. 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof
JPS57131794A (en) * 1980-12-31 1982-08-14 Fujisawa Pharmaceut Co Ltd Novel cephem compound or salt thereof, preparation of the same and preventing agent and remedy for microbism containing the same as active constituent
US4427677A (en) * 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4618606A (en) * 1982-11-17 1986-10-21 Toyama Chemical Co., Ltd. Antibiotic 7-(thiazolyl)-3-(pyrazinylmethyl) or (pyridazinylmethyl) cephalosporins
EP1059293A1 (en) * 1995-10-12 2000-12-13 Microcide Pharmaceuticals, Inc. Novel amino chlorothiazole compounds
IT1295935B1 (it) * 1997-10-30 1999-05-28 Acs Dobfar Spa Derivati aminotiazolici utili nella preparazione di antibiotici b -lattamici
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
EP2939677A1 (en) 2010-09-01 2015-11-04 Arena Pharmaceuticals, Inc. Administration of lorcaserin to indviduals with renal impairment
KR20130101524A (ko) 2010-09-01 2013-09-13 아레나 파마슈티칼스, 인크. 5-ht2c 아고니스트의 비-흡습성 염
WO2012030938A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
AU2011296003B2 (en) 2010-09-01 2015-11-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonist useful for weight management
KR20190128001A (ko) 2012-10-09 2019-11-13 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5168589A (xx) * 1974-12-06 1976-06-14 Shionogi Seiyaku Kk
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
AU534258B2 (en) 1984-01-12
PT68964A (de) 1979-01-01
IL56284A0 (en) 1979-03-12
HU184140B (en) 1984-07-30
DE2861043D1 (en) 1981-11-26
DE2758001A1 (de) 1979-07-12
NZ189266A (en) 1981-12-15
EP0002765B1 (de) 1981-09-02
IL56284A (en) 1983-03-31
EP0002765A1 (de) 1979-07-11
AU4284878A (en) 1979-06-28
ES476109A1 (es) 1979-10-16
ZA787209B (en) 1979-12-27
JPH0132226B2 (xx) 1989-06-29
PH15925A (en) 1983-04-26
GR65234B (en) 1980-07-30
DK578978A (da) 1979-06-25
IE782546L (en) 1979-06-24
CA1109461A (en) 1981-09-22
US4293550A (en) 1981-10-06
FI66007B (fi) 1984-04-30
AT365599B (de) 1982-01-25
JPS5495592A (en) 1979-07-28
IE48147B1 (en) 1984-10-17
ATA924178A (de) 1981-06-15
EG13762A (en) 1982-09-30
NO784366L (no) 1979-06-26
FI783960A (fi) 1979-06-25

Similar Documents

Publication Publication Date Title
FI66007C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara cefalosporinderivat
FI67705B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara (6,7r)-7-((z)-2-(2-aminotiazol-4-yl)-2-(substituerad oxiimi noacetamido)-(eventuellt substituerat pyridiniummetyl)cef-3 -e-4-karboxylatfoereningar
FI66618C (fi) Foerfarande foer framstaellning av terapeutiskt verkande 7-(2-(2-aminotiazol-4-yl)-2-(syn)-metoxi-iminoacetamido-cefalosporinderivat
FI87925B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefull kefemfoerening
US4603129A (en) Cephalosporin derivatives
KR830000835B1 (ko) 세팔로스포린 항생제의 제조방법
JPH0365350B2 (xx)
EP1221446B1 (en) Antibacterial cephalosporins
NO791730L (no) Cefalosporin-antibiotika.
HU193750B (en) Process for preparing 7-/2-(5-amino-1,2,4-thiadiazol-3-yl)-2-imino-acetamido/-3-/3-(quaternary-ammonio)-1-propen-1-yl/-ceph-3-em-4-carboxylates and pharmaceutics comprising such active substances
US5202315A (en) Cephalosporin compounds
CS219277B2 (en) Method of making the 3/tetrazolo/1,5-b/pyridazinyl-thiome thyl/-derivative oxy-imino-substituted cefalosporine
FI74020C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 7- -/ -syn-metoxiimino- -(2-aminotiazol-4-yl) acetamido/-3-/(1,2,3-tiadiazol-5-yltio)metyl/-3-cefem-4-karboxylsyraderivat
FI56843C (fi) Foerfarande foer framstaellning av antibakteriella 7-(alfa-amino-p-hydroxifenylacetamido)-3-heterocykliska tiometylcefalosporiner
HU221429B (en) 7-acyl-3-(substituted carbamoyloxy)-methyl-cef-3-em-4-carboxylic acid derivatives, process for their preparation and pharmaceutical compositions comprising such compounds
US3814755A (en) 7-(omikron-aminomethylphenylacetamido)-3-(tetrazolo(4,5-b)pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid
HU184805B (en) Process for preparing new substituted alkyl-oximes derived from 7-/2-amino-4-thazolyl/-acetamido-cephalosporanic acid
FI66005B (fi) Foerfarande foer framstaellning av antibakteriellt verkande 7-alfa,alfa-disubstituerad-acetamido)-3-substituerad-3-cefe m--karboxylsyras syn-isomer
CA1114808A (en) Derivatives of 7-¬substituted oxyiminoacetamido| cephalosporins
US4507487A (en) Chemical compounds
KAWABATA et al. STUDIES ON β-LACTAM ANTIBIOTICS XIII. SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 7β-[(Z)-2-ARYL-2-CARBOXYMETHOXYIMINOACETAMIDO]-3-VINYLCEPHALOSPORINS
US3953439A (en) Substituted phenylglycylcephalosporins
IE53116B1 (en) Cephem derivatives and a process for their preparation
FR2475046A1 (fr) Nouveaux derives (2-imino-4-thiazolyl)-substitues d'oximinocephalosporines, utiles notamment comme agents antibacteriens, et leur procede de preparation
US4107440A (en) Intermediates for preparing substituted phenylglycylcephalosporins

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT